Skip to content

Envoy Medical COCH Other comprehensive income (loss)

Other comprehensive income (loss) at other companies

Seaboard logo
SeaboardSEB
$7M+150%
Regenxbio logo
RegenxbioRGNX
-$183K-771%
TFS Financial logo
TFS FinancialTFSL
$12.43M+148%
MGP Ingredients logo
MGP IngredientsMGPI
-$265K-190%
The RMR Group logo
The RMR GroupRMR
$688K+2,452%
Mativ Holdings logo
Mativ HoldingsMATV
-$8.9M-368%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossNetOfTax.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's other comprehensive income (loss).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's other comprehensive income (loss)?
Envoy Medical (COCH) reported other comprehensive income (loss) of -$1K in Q1 2026.
How has Envoy Medical's other comprehensive income (loss) changed year-over-year?
Envoy Medical's other comprehensive income (loss) decreased by 116.7% year-over-year, from $6K to -$1K.
What does other comprehensive income (loss) mean?
Represents the net change in equity resulting from items not included in net income, such as foreign currency translation adjustments or unrealized gains and losses on certain investments. It provides a broader view of financial performance by capturing volatility in equity that bypasses the income statement.